PuSH - Publication Server of Helmholtz Zentrum München

Flach, S.* ; Kumbrink, J.* ; Walz, C.* ; Hess J. ; Drexler, G. ; Belka, C. ; Canis, M. ; Jung, A.* ; Baumeister, P.

Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.

J. Oral Pathol. Med. 51, 738-746 (2022)
Publ. Version/Full Text Research data DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Background: Head and neck squamous cell carcinoma remains a substantial burden to global health. Despite evolving therapies, 5-year survival is <50% and unlike in other cancers, reliable molecular biomarkers to guide treatment do not exist. Methods: We performed targeted panel next-generation sequencing to analyse somatic variants from primary and recurrent tumour tissue, corresponding resection margins and cell-free DNA from intra-operatively collected plasma samples from eight patients with human papillomavirus-negative head and neck squamous cell carcinoma. Patients were primarily treated with curative-intent surgery and received subsequent adjuvant treatment. Results: The most frequently mutated gene was TP53. Other mutated genes included NOTCH1, NF1 and CDKN2A among others. A total of 20.8% of variants were shared between primary tumour and resection margin. Out of all the variants detected, 37.5% were shared between cell-free DNA and primary tumour, whereas 12.5% were commonly found in cell-free DNA, primary tumour and resection margin. Mutational profiling was able to distinguish between a locoregional recurrence and a second primary tumour by identifying a different TP53 mutation in the primary tumour compared to the recurrent tumour in addition to private FBXW7 and CTNNB1 mutations. We also identified identical TP53 and PIK3CA mutations in another primary tumour and corresponding recurrence. Conclusion: Molecular profiling of cell-free DNA and resection margins has potential applications in clinical practice to guide future treatment decisions.
Impact Factor
Scopus SNIP
Altmetric
3.539
1.498
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Cell-free Dna ; Hnscc ; Liquid Biopsy ; Next-generation Sequencing ; Resection Margins
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0904-2512
e-ISSN 1600-0714
Quellenangaben Volume: 51, Issue: 8, Pages: 738-746 Article Number: , Supplement: ,
Publisher Wiley
Reviewing status Peer reviewed
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30203 - Molecular Targets and Therapies
Research field(s) Radiation Sciences
PSP Element(s) G-521800-001
G-501000-001
Grants Vereinzur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der LMU München e.V.
Munich Clinician Scientist Programme
Scopus ID 85135863634
PubMed ID 35895622
Erfassungsdatum 2022-11-09